The Application of Near Infrared Spectroscopy (NIRS) in the Detection of Lower Limb Compartment Syndrome
Launched by UNIVERSITY HOSPITAL BIRMINGHAM NHS FOUNDATION TRUST · Jun 15, 2009
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients with one or more of the following injuries:
- • tibial fracture
- • crush injury/soft tissue injury to lower limb without fracture
- • pelvic fracture
- • major vascular injury below the aortic bifurcation
- • 2 or more long bone fractures
- • Any patient sustaining a traumatic injury with a base deficit ≥ 6 mEq/L within 12 hours of Hospital admission.
- • Any patient receiving ≥ 6 units packed red blood cells within 12 hours of hospital admission.
- Exclusion Criteria:
- • Age ≤ 16 years are excluded by design, as all pediatric cases are managed at Birmingham Childrens Hospital. There is no upper age limit.
- • Bilateral lower limb amputees.
- • Individuals who have received methylene blue within the previous week or during the study period.
- • Patient refusal to participated in the trial.
- • In the case of incapacitated patients, refusal by the patient's relatives/representatives, or where no representative can be identified.
About University Hospital Birmingham Nhs Foundation Trust
The University Hospital Birmingham NHS Foundation Trust is a leading academic health institution dedicated to providing exceptional patient care, advancing medical research, and enhancing education in the healthcare field. As a prominent sponsor of clinical trials, the Trust collaborates with a network of researchers and healthcare professionals to facilitate innovative studies aimed at improving treatment outcomes and patient experiences. With a strong commitment to ethical standards and patient safety, the Trust leverages its extensive resources and expertise to drive forward clinical research initiatives that contribute to the advancement of medical science and the health of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Tom Barker, MBChB, MRCS
Principal Investigator
University Hospitals Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials